RetroSense Therapeutics

About This Project

RetroSense Therapeutics is a biotechnology company developing game-changing gene therapies designed to restore vision in patients suffering from blindness due to retinitis pigmentosa (RP) and advanced dry age—related macular degeneration (advanced dry—AMD). There are currently no FDA approved drugs to improve or restore vision in patients with these retinal degenerative conditions. RetroSense Therapeutics is led by a team of seasoned veterans with experience in developing some of the most successful drugs on the market and numerous successful new business ventures.